WGSWW
Income statement / Annual
Last year (2023), GeneDx Holdings Corp.'s total revenue was $202.57 M,
a decrease of 13.69% from the previous year.
In 2023, GeneDx Holdings Corp.'s net income was -$175.77 M.
See GeneDx Holdings Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$202.57 M
|
$234.69 M
|
$212.20 M
|
$179.32 M
|
$196.17 M
|
| Cost of Revenue |
$141.94 M |
$261.44 M |
$228.80 M |
$175.30 M |
$113.39 M |
| Gross Profit |
$60.62 M |
-$26.75 M |
-$16.60 M |
$4.03 M |
$82.79 M |
| Gross Profit Ratio |
0.3 |
-0.11 |
-0.08 |
0.02 |
0.42 |
| Research and Development
Expenses |
$58.27 M
|
$86.20 M
|
$105.16 M
|
$72.70 M
|
$34.91 M
|
| General & Administrative
Expenses |
$133.76 M
|
$203.33 M
|
$205.99 M
|
$100.74 M
|
$29.48 M
|
| Selling & Marketing
Expenses |
$60.96 M
|
$134.91 M
|
$112.74 M
|
$63.18 M
|
$39.35 M
|
| Selling, General &
Administrative Expenses |
$194.71 M
|
$338.24 M
|
$318.73 M
|
$163.93 M
|
$68.84 M
|
| Other Expenses |
-$28.69 M |
$6.31 M |
$5.66 M |
$9.40 M |
$9.45 M |
| Operating Expenses |
$224.28 M |
$430.76 M |
$429.55 M |
$246.02 M |
$113.20 M |
| Cost And Expenses |
$366.23 M |
$692.20 M |
$658.34 M |
$421.32 M |
$226.59 M |
| Interest Income |
$1.11 M |
$2.54 M |
$79,000.00 |
$506,000.00 |
$988,000.00 |
| Interest Expense |
$0.00 |
$3.21 M |
$2.84 M |
$2.47 M |
$783,000.00 |
| Depreciation &
Amortization |
$33.73 M
|
$63.03 M
|
$23.36 M
|
$14.13 M
|
$6.41 M
|
| EBITDA |
-$136.46 M
|
-$398.20 M
|
-$219.19 M
|
-$224.73 M
|
-$22.51 M
|
| EBITDA Ratio |
-0.67 |
-1.69 |
-2 |
-1.27 |
-0.11 |
| Operating Income Ratio
|
-0.81
|
-2.84
|
-2.1
|
-1.35
|
-0.16
|
| Total Other
Income/Expenses Net |
-$13.03 M
|
$69.62 M
|
$200.76 M
|
$654,000.00
|
$709,000.00
|
| Income Before Tax |
-$176.69 M |
-$598.03 M |
-$245.39 M |
-$241.34 M |
-$29.70 M |
| Income Before Tax Ratio
|
-0.87
|
-2.55
|
-1.16
|
-1.35
|
-0.15
|
| Income Tax Expense |
-$926,000.00 |
-$49.05 M |
$21.57 M |
$5.10 M |
$1.29 M |
| Net Income |
-$175.77 M |
-$548.98 M |
-$245.39 M |
-$246.44 M |
-$30.99 M |
| Net Income Ratio |
-0.87 |
-2.34 |
-1.16 |
-1.37 |
-0.16 |
| EPS |
-7.23 |
-53.63 |
-74.93 |
-1584951.85 |
-4.26 |
| EPS Diluted |
-7.23 |
-53.63 |
-74.93 |
-1584951.85 |
-4.26 |
| Weighted Average Shares
Out |
$24.31 M
|
$10.24 M
|
$3.28 M
|
$155.48
|
$7.28 M
|
| Weighted Average Shares
Out Diluted |
$24.31 M
|
$10.24 M
|
$3.28 M
|
$155.48
|
$7.28 M
|
| Link |
|
|
|
|
|
